Showing results (3051-3060 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|March 2, 2013
Fabry disease and cardiovascular involvementAris Anastasakis, Efstathios Papatheodorou, Alexandros Klavdios SteriotisCurrent Pharmaceutical Design|March 2, 2013
Cutaneous complications of Anderson-Fabry diseasePistone Giuseppe, Rizzo Daniele, Bongiorno Maria RitaCurrent Pharmaceutical Design|March 2, 2013
Renal complications of Fabry diseaseNikolina Basic-Jukic, Petar Kes, Marijana Coric, et al.Current Pharmaceutical Design|March 2, 2013
Histone acetylation: from code to web and router via intrinsically disordered regionsMasami HorikoshiCurrent Pharmaceutical Design|March 2, 2013
Histone post-translational modifications to target memory-related diseasesBarbara MontiCurrent Pharmaceutical Design|March 2, 2013
Histone post-translational modifications in Huntington's and Parkinson's diseasesLuis Emiliano Peña-Altamira, Elisabetta Polazzi, Barbara MontiCurrent Pharmaceutical Design|March 2, 2013
Opiate-induced analgesia: contributions from mu, delta and kappa opioid receptors mouse mutantsClaire Gavériaux-RuffCurrent Pharmaceutical Design|March 2, 2013
Essential structure of the κ opioid receptor agonist nalfurafine for binding to the κ receptorHiroshi Nagase, Hideaki FujiiCurrent Pharmaceutical Design|March 2, 2013
Roles of p38-MAPK in insulin resistant heart: evidence from bench to future bedside applicationSarawut Kumphune, Siriporn Chattipakorn, Nipon ChattipakornCurrent Pharmaceutical Design|March 9, 2013
Restenosis treatments using nanoparticle-based drug delivery systemsZi Gu, Barbara E Rolfe, Anita C Thomas, et al.Pageof 1,008